HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetrachlorodibenzodioxin: a survey of subjects ten years after exposure.

Abstract
Ten years after an incident following which 79 workers developed chloracne due to exposure to tetrachlorodibenzodioxin a study was undertaken to establish the current state of health of the affected employees remaining in the company's (Coalite Oils and Chemicals Ltd, a subsidiary company of Coalite Group Ltd) employment. The opportunity was used to examine effects on mortality, morbidity, carcinogenesis, reproduction, teratogenicity, fetotoxicity, biochemistry, immunology, and genetic change. Concurrently, control groups were established with which to make comparison. The control groups selected from within the works matched the study group in respect of sex and age but it was not possible to match them for occupation and social status. Half the affected subjects still have minor chloracne. Other than this there is no evidence that they have been adversely affected in any way.
AuthorsG May
JournalBritish journal of industrial medicine (Br J Ind Med) Vol. 39 Issue 2 Pg. 128-35 (May 1982) ISSN: 0007-1072 [Print] England
PMID6121580 (Publication Type: Journal Article)
Chemical References
  • Chlorophenols
  • Dioxins
  • Polychlorinated Dibenzodioxins
  • Triglycerides
  • 2,4,5-trichlorophenol
  • Cholesterol
  • gamma-Glutamyltransferase
  • Alkaline Phosphatase
  • Glucaric Acid
  • Bilirubin
Topics
  • Abortion, Spontaneous (chemically induced)
  • Accidents, Occupational
  • Acne Vulgaris (chemically induced)
  • Adult
  • Alkaline Phosphatase (analysis)
  • Bilirubin (blood)
  • Chemical Industry
  • Chlorophenols (chemical synthesis)
  • Cholesterol (analysis)
  • Dioxins (poisoning)
  • England
  • Female
  • Glucaric Acid (urine)
  • Humans
  • Infant, Newborn
  • Male
  • Occupational Diseases (chemically induced)
  • Polychlorinated Dibenzodioxins (poisoning)
  • Pregnancy
  • Time Factors
  • Triglycerides (analysis)
  • gamma-Glutamyltransferase (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: